Orencia Gains Psoriatic Arthritis Approval in Europe
Aug 2, 2017
Patients demonstrated improved disease response in 2 clinical trials.
Expanded role for MRI and 2 recently approved treatment options. (©Gemalbarra/Shutterstock.com)
Psoriatic Arthritis
7 Treatment Guidelines for Knee and Hip Replacement Surgery
Jun 23, 2017
In this slideshow, we highlight newly released treatment recommendations for rheumatic disease patients undergoing total hip or total knee arthroplasty.
New Antirheumatic Drug Guidelines for Hip and Knee Arthroplasty
Jun 23, 2017
Rheumatic patients are more prone to complications post knee and hip surgery. Two physician associations have penned new treatment guidelines.
Rethinking Pain Management in Psoriatic Arthritis
Jun 20, 2017
EULAR 20017: Despite the use of biologic therapy, pain ranging from mild to severe is a persistent problem for psoriatic arthritis patients, researchers reported at EULAR 2017.
The Role of Innate Lymphoid Cells in Inflammatory Rheumatic Disease
May 26, 2017
Innate lymphoid cells have a clear role in rheumatic disease and its related inflammatory process.
Biosimilar Proves to be OK for Switching
May 18, 2017
Clinical trial shows that switching from the infliximab originator to its biosimilar does not compromise safety or effectiveness of treatment.
Prior Biologic Use Affects TNFi Treatment Persistence
May 8, 2017
A history of having taken biologics affects whether patients will adhere to prescribed TNFi therapy, researchers show.
Identifying Affected Tissues and Disease Severity in PsA
Apr 14, 2017
From skin to joint issues, the list of symptoms associated with psoriatic arthritis is long and not every patient exhibits the same symptoms. In this slideshow, we highlight PsA symptoms and treatments.
Disillusioned PsA Patients Draw the Line at Biologics
Apr 3, 2017
There are two types of PsA patients: Biologic naïve patients who take medication persistence seriously and patients who've given up due to a history of failed TNFi therapy.
Reducing Treatment Risks in PsA
Apr 3, 2017
To reduce risks while improving quality of life, a comprehensive care approach for psoriatic arthritis patients requires the recognition of treatment risks and treatment options.